Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder

Biological Psychiatry

Volumn 45, Issue 9, 1999, Pages 1178-1189

  Karayiorgou, Maria ^a   Sobin, Christina ^a   Blundell, Maude L ^a   Galke, Brandi L ^a   Malinova, Lubomira ^a   Goldberg, Pablo ^a   Ott, Jurg ^a   Gogos, Joseph A ^a,b  

^a ROCKEFELLER UNIVERSITY   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Catechol O methyltransferase; Gender differences; Gene(s); Major depressive disorder; Monoamine oxidase A; Obsessive compulsive disorder

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; CATECHOL METHYLTRANSFERASE;

ADULT; ARTICLE; COMPULSION; ENZYME ACTIVITY; FAMILY; FEMALE; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; INHERITANCE; MAJOR CLINICAL STUDY; MALE; MONOAMINE METABOLISM; OBSESSION; PRIORITY JOURNAL; SEX DIFFERENCE;

ADOLESCENT; ADULT; CATECHOL O-METHYLTRANSFERASE; FEMALE; GENOTYPE; HUMANS; MALE; MONOAMINE OXIDASE; OBSESSIVE-COMPULSIVE DISORDER; PSYCHIATRIC STATUS RATING SCALES; SEX FACTORS; X CHROMOSOME;

EID: 0033135862     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00319-9     Document Type: Article

References (66)

1. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. 1994;American Psychiatric Press, Washington, DC.
2. Breakefield X.O., Giller E.L. Jr, Nurnberger J.I. Jr, et al. Monoamine oxidase type A in fibroblasts from patients with bipolar depressive illness. Psychiatry Res. 2:1980;307-314.
3. Brunner H.G., Nelen M.R., van Zandvoort P., et al. X-linked borderline mental retardation with prominent behavioural disturbance Phenotype, genetic localization, and evidence for disturbed monoamine metabolism . Am J Hum Genet. 52:1993;1032-1039.
4. Brunner H.G., Nelen M., Breakefield X.O., et al. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science. 262:1993;578-580.
5. Campbell I.C., Robinson D.S., Lovenberg W., et al. The effects of chronic regimens of clorgyline and pargyline on monoamine metabolism in the rat brain. J Neurochem. 32:1979;49-55.
6. Cases O., Seif I., Grimsby J., et al. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science. 268:1995;1763-1766.
7. Castle D.J., Deale A., Marks I.M. Gender differences in obsessive compulsive disorder. Austr N Z J Psychiatry. 29:1995;114-117.
8. Collier D.A., Sham P.C. Catch me if you can are catechol- and indolamine genes pleiotropic QTLs for common mental disorders? Mol Psychiatry. 2:1997;181-183.
9. de la Chapelle A., Sankila E.M., Lindlof M., et al. Norrie disease caused by a gene deletion allowing carrier detection and prenatal diagnosis. Clin Genet. 28:1985;317-320.
10. Dominguez R.A., Mestre S.M. Management of treatment-refractory obsessive compulsive disorder patients. J Clin Psychiatry. 55:(suppl1):1994;86-91.
11. Gogos J.A., Morgan M., Luine V., et al. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci U S A. 95:1998;9991-9996.
12. Goodman W.K., Price L.H., Rasmussen S.A. The Yale-Brown Obsessive Compulsive Scale (Y-BOCS) Part I. Development, Use, and Reliability . Arch Gen Psychiatry. 46:1989;1006-1011.
13. Goodwin D.W., Guze S.B., Robins E. Follow-up studies in obsessional neurosis. Arch Gen Psychiatry. 20:1969;182-187.
14. Greist J.H., Jefferson J.W., Kobak K.A., et al. Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. Arch Gen Psychiatry. 52:1995;53-60.
15. Grossman M.H., Littrell J.B., Weinstein R., et al. Identification of the possible basis for inherited differences in human catechol-O-methyltransferase. Trans Neurosci Soc. 18:1992;70.
16. Hotamisligil G.S., Breakefield X.O. Human monoamine oxidase A gene determines levels of enzyme activity. Am J Hum Genet. 49:1991;383-392.
17. Hsu Y.P., Powell J.F., Sims K.B., et al. Molecular genetics of the monoamine oxidases. J Neurochem. 53:1989;12-18.
18. Hsu Y.P., Weyler W., Chen S., et al. Structural features of human monoamine oxidase A elucidated from cDNA and peptide sequences. J Neurochem. 51:1988;1321-1324.
19. Insel T.R., Murphy D.L., Cohen R.M., et al. Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline. Arch Gen Psychiatry. 40:1983;605-612.
20. Jenike M.A., Baer L., Minichiello W.E., et al. Placebo-controlled trial of fluoxetine and phenelzine for obsessive-compulsive disorder. Am J Psychiatry. 154:1997;1261-1264.
21. Karayiorgou M., Altemus M., Galke B.L., et al. Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. Proc Natl Acad Sci U S A. 94:1997;4572-4575.
22. Karayiorgou M., Gogos J.A., Galke B.L., et al. Identification of sequence variants and analysis of the role of the COMT gene in schizophrenia susceptibility. Biol Psychiatry. 43:1998;425-431.
23. Karayiorgou M., Morris M.A., Morrow B., et al. Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc Natl Acad Sci U S A. 92:1995;7612-7616.
24. Karno M., Golding J.M., Sorenson S.B., et al. The epidemiology of obsessive-compulsive disorder in five U.S. communities. Arch Gen Psychiatry. 45:1988;1094-1099.
25. Karoum F., Chrapusta S.J., Egan M.F. 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model . J Neurochem. 63:1994;972-979.
26. Lachman H.M., Papolos D.F., Saito T., et al. Human catechol-O-methyltransferase pharmacogenetics description of a functional polymorphism and its potential application to neuropsychiatric disorders . Pharmacogenetics. 6:1996;243-250.
27. Lander E.S., Kruglyak L. Genetic dissection of complex traits guidelines for interpreting and reporting linkage results . Nat Genet. 11:1995;241-247.
28. Leckman J.F., Riddle M.A., Hardin M.T., et al. The Yale Global Tic Severity Scale Initial testing of a clinician-rated scale of tic severity . J Am Acad Child Adolesc Psychiatry. 28:1989;566-573.
29. Lenane M.C., Swedo S.E., Leonard H.L., et al. Psychiatric disorders in first degree relatives of children and adolescents with obsessive compulsive disorder. J Am Acad Child Adolesc Psychiatry. 29:1990;407-412.
30. Lensi P., Cassano G.B., Correddu G., et al. Obsessive-compulsive disorder Familial-developmental history, symptomatology, comorbidity and course with special reference to gender-related differences . Br J Psychiatry. 169:1996;101-107.
31. Levy E.R., Powell J.F., Buckle V.J., et al. Localization of human monoamine oxidase A gene to Xp11.23-11.4 by in situ hybridization implications for Norrie disease . Genomics. 5:1989;368-370.
32. Liebowitz M.R., Hollander E., Schneier F., et al. Reversible and irreversible monoamine oxidase inhibitors in other psychiatric disorders. Acta Psychiatr Scand. 360:(suppl1):1990;29-34.
33. Lotta T., Vidgren J., Tilgmann C., et al. Kinetics of human soluble and membrane bound catechol-O-methyltransferase a revised mechanism and description of the thermolabile variant of the enzyme . Biochemistry. 34:1995;4202-4210.
34. Luine V.N., Khylchevskaya R.I., McEwen B.S. Effect of gonadal steroids on activities of monoamine oxidase and choline acetylase in rat brain. Brain Res. 86:1975;293-306.
35. McDougle C.J., Goodman W.K., Leckman J.F., et al. Haloperidol addition in fluvoxamine-refractory obsessive compulsive disorder a double-blind, placebo-controlled study in patients with and without tics . Arch Gen Psychiatry. 51:1994;302-308.
36. McDougle C.J., Goodman W.K., Price L.H. The pharmacotherapy of obsessive-compulsive disorder. Pharmacopsychiatry. 26:(suppl I):1993;24-29.
37. Melo J.A., Shendure J., Pociask K., et al. Identification of sex-specific quantitative trait loci controlling alcohol preference in C57BL/6 mice. Nat Genet. 13:1996;147-153.
38. Mogil J.S., Richards S.P., O'Toole L.A., et al. Identification of a sex-specific quantitative trait locus mediating nonopioid stress-induced analgesia in female mice. J Neurosci. 17:1997;7995-8002.
39. Murphy D.L., Greenberg B., Altemus M., et al. The neuropharmacology and neurobiology of obsessive compulsive disorder An update on the serotonin hypothesis . Westenberg H.G.M., Murphy D.L., Boer J.A.D. Advances in the Neurobiology of Anxiety Disorders. 1995;278-298 Wiley Publications, New York.
40. Napolitano A., Cesura A.M., Da Prada M. The role of monoamine oxidase and catechol-O-methyltransferase in dopaminergic neurotransmission. J Neural Transm. 45:(suppl):1995;35-45.
41. Nurnberger J.I., Blehar M.C., Kaufmann C.A., et al. Diagnostic Interview for Genetic Studies Rationale, Unique Features, and Training . Arch Gen Psychiatry. 51:1994;949.
42. Ovtscharoff W., Eusterschulte B., Zienecker R., et al. Sex differences in densities of dopaminergic fibers and GABAergic neurons in the prenatal rat striatum. J Comp Neurol. 323:1992;299-304.
43. Papolos D.F., Faedda G.L., Veitm S., et al. Bipolar spectrum disorders in patients diagnosed with velo-cardio-facial syndrome does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder? Am J Psychiatry. 153:1996;1541-1547.
44. Pato M.T., Zohar J. Clomipramine in the Treatment of Obsessive-Compulsive Disorder. Pato M.T., Zohar J. In Current Treatments of Obsessive Compulsive Disorder. 1991;American Psychiatric Press, Washington, DC.
45. Pauls D.L., Alsobrook J.P., Phil M., et al. A family study of obsessive-compulsive disorder. Am J Psychiatry. 152:1995;76-84.
46. Paykel E.S. Clinical efficacy of reversible and selective inhibitors of monoamine oxidase A in major depression. Acta Psychiatr Scand. 386:(suppl):1995;22-27.
47. Pulver A.E., Nestadt G., Goldberg R., et al. Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. J Nerv Ment Dis. 182:1994;476-478.
48. Puzynski S., Bidzinski A., Mrozek S., et al. Studies on biogenic amine metabolizing enzymes (DBH, COMT, MAO) and pathogenesis of affective illness. II. Erythrocyte catechol-O-methyltransferase activity in endogenous depression. Acta Psychiatr Scand. 67:1983;96-100.
49. Rapoport J.L. The Boy Who Couldn't Stop Washing. 1989;Dutton, New York.
50. Rasmussen S.A., Eisen J.L. The epidemiology and clinical features of obsessive compulsive disorder. Psychiatr Clin North Am. 15:1992;743-758.
51. Rasmussen S.A., Eisen J.L. The epidemiology and differential diagnosis of obsessive compulsive disorder. J Clin Psychiatry. 55:1994;5-10.
52. Risch N., Merikangas K. The future of genetic studies of complex human diseases. Science. 273:1996;1516-1517.
53. Rubinstein P., Walker M., Carpenter C., et al. Genetics of HLA disease associations the use of the haplotype relative risk (HRR) and the "haplo-delta" (Dh) estimates in juvenile diabetes from three racial groups . Hum Immunol. 3:1981;384.
54. Rubinsztein D.C., Leggo J., Goodburn S., et al. Genetic association between monoamine oxidase A microsatellite and RFLP alleles and bipolar affective disorder analysis and meta-analysis . Hum Mol Genet. 5:1996;779-782.
55. Schaid D.J., Sommer S.S. Comparison of statistics for candidate-gene association studies using cases and parents. Am J Hum Genet. 55:1994;402-409.
56. Sims K.B., de la Chapelle A., Norio R., et al. Monoamine oxidase deficiency in males with an X chromosome deletion. Neuron. 2:1989;1069-1076.
57. Sobin C., Blundell M., Weiller F., Gavigan C., Haiman C., Karayiorgou M. . The phenotypic characteristics of obsessive compulsive disorders ascertained in adulthood. J Psychiatr Res. 33:1999;256-263.
58. Spielman R.S., McGinnis R.E., Ewens W.J. Transmission test for linkage disequilibrium the insulin gene region and insulin-dependent diabetes mellitus (IDDM) . Am J Hum Genet. 52:1993;506-516.
59. Terwilliger J., Ott J. A haplotype-based "haplotype relative risk" approach to detecting allelic associations. Hum Hered. 42:1992;337-346.
60. Thorpe L.W., Westlund K.N., Kochersperger L.M., et al. Immunocytochemical localization of monoamine oxidases A and B in human peripheral tissues and brain. J Histochem Cytochem. 35:1987;23-32.
61. Vathy I., Katay L., Mini K.N. Sexually dimorphic effects of prenatal cocaine on adult sexual behavior and brain catecholamines in rats. Brain Res Dev Brain Res. 73:1993;115-122.
62. Waldman I.D., Robinson B.F., Feigon S.A. Linkage Disequilibrium between the Dopamine Transporter Gene (DAT1) and Bipolar Disorder Extending the Transmission Disequilibrium Test (TDT) to Examine Genetic Heterogeneity . Genet Epidemiol. 14:1997;699-704.
63. Weissman M.M., Bland R.C., Canino G.J., et al. The cross national epidemiology of obsessive compulsive disorder. J Clin Psychiatry. 55:1994;5-10.
64. Weyler W., Hsu Y.P., Breakefield X.O. Biochemistry and genetics of monoamine oxidase. Pharmacol Ther. 47:1990;391-417.
65. Yellman C., Tao H., He B., et al. Conserved and sexually dimorphic behavioral responses to biogenic amines in decapitated Drosophila. Proc Natl Acad Sci U S A. 94:1997;4131-4136.
66. Zohar J., Pato M.T. Diagnostic Considerations. Pato M.T., Zohar J. In Current Treatments of Obsessive Compulsive Disorder. 1991;American Psychiatric Press, Washington, DC.